# Lori Cashman

> Lori Cashman is a seed investor at Victress Capital (Boston) backing Coffee and Brewing. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Victress Capital](https://shizune.co/investors/profile/victress-capital)
- Location: Boston, United States
- Total investments: 3
- Last investment: Jan 2023
- Lead investor: 67%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/lori-cashman

Lori Cashman is a seed investor at Victress Capital in Boston focused on Coffee and Brewing. Lori Cashman is the General Partner at Visible Ventures (formerly Victress Capital).

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Coffee | 1 | 33% |
| Brewing | 1 | 33% |
| Wellness | 1 | 33% |
| Cosmetics | 1 | 33% |
| Health Care | 1 | 33% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 33% |
| Series B | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Explorer Cold Brew | Explorer Cold Brew is a specialty coffee company that produces cold brew concentrates. The company's concentrated cold brew makes any coffee beverage consumers want - from lattes and cappuccinos to cocktails, smoothies, and more. Consumers can pick from 4 different caffeine levels and get it delivered directly to their doors. | $2.5M | Seed | Jan 02, 2023 |  |
| Droplette | Droplette is their patent-pending transdermal delivery system for delivery of drugs up to 60% larger than current treatments deep into skin over large surface areas. Their unique device is painless, contact free, portable and generates no disposables. It is designed to deliver antibiotics for serious ulcers and skin infections, reducing risksecondary complications or antibiotic resistance. Future applications include localized delivery of chemotherapeutics for skin cancer and drugs for anti-aging. | $21M | Series B | Dec 03, 2021 |  |
| Droplette | Droplette is their patent-pending transdermal delivery system for delivery of drugs up to 60% larger than current treatments deep into skin over large surface areas. Their unique device is painless, contact free, portable and generates no disposables. It is designed to deliver antibiotics for serious ulcers and skin infections, reducing risksecondary complications or antibiotic resistance. Future applications include localized delivery of chemotherapeutics for skin cancer and drugs for anti-aging. | $21M | Series B | Dec 03, 2021 |  |

3 of 3 investments shown.

## Co-investors
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund, 2 deals together
- [Amplifyher Ventures](https://shizune.co/investors/profile/amplifyher-ventures) — VC Fund, 2 deals together
- [Bolt](https://shizune.co/investors/profile/bolt-io) — VC Fund, 2 deals together
- [Green D Ventures](https://shizune.co/investors/profile/green-d-ventures-a230) — VC Fund, 2 deals together
- [K5 Global](https://shizune.co/investors/profile/k5-global) — VC Fund, 2 deals together
- [Spark Capital](https://shizune.co/investors/profile/spark-capital) — VC Fund, 2 deals together

## About Victress Capital

VC Fund · Boston, United States

Victress Capital invests in technology-enabled consumer startups led by diverse leadership. It provides visionary and diverse founding teams in the consumer space with capital and resources for growth by leveraging its 40+ years of consumer operating and investing experience. The firm was founded in 2016 and is headquartered in Boston,Massachusetts.

4 contacts available at Victress Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Lori Cashman | General Partner | https://shizune.co/investors/profile/lori-cashman |
| Suzanne Norris | General Partner | https://shizune.co/investors/profile/suzanne-norris |
| Yuriy Dovzhansky | Vice President | https://shizune.co/investors/profile/yuriy-dovzhansky |
| Alyssa Fanelli | Relationship Management | https://shizune.co/investors/profile/alyssa-fanelli-23da |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Lori Cashman invest in?

Lori Cashman invests primarily in Coffee, Brewing and Wellness startups, most often at Seed and Series B stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Lori Cashman last invest?

The most recent investment recorded for Lori Cashman closed in Jan 2023. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co